Product Information

ARMODAFINIL 150 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.7954 per EA under NDC 00378343293. Its NADAC has been published 518 times since Sep 21, 2016.

FDA first approved this application on Jun 1, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ARMODAFINIL 150 MG TABLET

armodafinil
$0.7954per EA
DEA Schedule CIV

Strength

150 mg/1

NDC

00378343293

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ARMODAFINIL

Approval Type

Generic (ANDA)

FDA Application

ANDA200043

FDA Approved

6/1/2012

TE Code

AB

On Market Since

6/1/2016

Price Statistics

The NADAC for ARMODAFINIL 150 MG TABLET has been published 518 times since Sep 21, 2016, and over the history we have for it it has declined 95.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7954 per EA
All-time high$17.2781 (Dec 14, 2016)
All-time low$0.5352 (Nov 20, 2024)
52-week high$0.8371
52-week low$0.7517
Median price$0.8640
Average price$1.6693
Largest weekly change-87.3% (Feb 22, 2017)
Weeks tracked518
Tracking sinceSep 21, 2016

Price History

1W

-0.3%

1M

-0.3%

3M

+1.6%

6M

+0.7%

1Y

+5.8%

3Y

-3.4%

5Y

-3.4%

All

-95.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the armodafinil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of ARMODAFINIL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 150 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.7954 per EA (NDC 00378343293), effective Aug 19, 2026.

How has the price of ARMODAFINIL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for ARMODAFINIL 150 MG TABLET has declined 95.4%. It has been tracked across 518 weekly CMS publications since Sep 21, 2016.

What are the highest and lowest recorded NADAC prices for ARMODAFINIL 150 MG TABLET?

Since Sep 21, 2016, the NADAC for ARMODAFINIL 150 MG TABLET has ranged from a low of $0.5352 (Nov 20, 2024) to a high of $17.2781 (Dec 14, 2016), with a median of $0.8640 per EA.

Are there cheaper alternatives to ARMODAFINIL 150 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ARMODAFINIL 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ARMODAFINIL 150 MG TABLET?

ARMODAFINIL 150 MG TABLET (NDC 00378343293) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.